This medical app helps healthcare professionals determine the appropriate dosage and prescription for new oral anticoagulants (NOACs) like dabigatran, rivaroxaban, apixaban, and edoxaban. It focuses on adult patients with non-valvular atrial fibrillation and at least one risk factor for stroke.
NAO by ANMCO(ASSOCIAZIONE NAZIONALE MEDICI CARDIOLOGI OSPEDALIERI)
Editor's Choice
๐ฅ Medical
0.0(0 ratings)
Free













